Kurt Andersson - Publications

Affiliations: 
Karolinska Institute, Stockholm, Sweden 

71 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2013 Erlandsson MC, Svensson MD, Jonsson IM, Bian L, Ambartsumian N, Andersson S, Peng Z, Vääräniemi J, Ohlsson C, Andersson KM, Bokarewa MI. Expression of metastasin S100A4 is essential for bone resorption and regulates osteoclast function. Biochimica Et Biophysica Acta. 1833: 2653-63. PMID 23830916 DOI: 10.1016/j.bbamcr.2013.06.020  0.354
2013 Svensson MN, Andersson SE, Erlandsson MC, Jonsson IM, Ekwall AK, Andersson KM, Nilsson A, Bian L, Brisslert M, Bokarewa MI. Fms-like tyrosine kinase 3 ligand controls formation of regulatory T cells in autoimmune arthritis. Plos One. 8: e54884. PMID 23349985 DOI: 10.1371/journal.pone.0054884  0.361
2012 Andersson SE, Svensson MN, Erlandsson MC, Dehlin M, Andersson KM, Bokarewa MI. Activation of Fms-like tyrosine kinase 3 signaling enhances survivin expression in a mouse model of rheumatoid arthritis. Plos One. 7: e47668. PMID 23082191 DOI: 10.1371/journal.pone.0047668  0.362
2012 Andersson K, Fuxe K, Eneroth P, Gustafsson JA, Skett P. On the catecholamine control of growth hormone regulation. Evidence for discrete changes in dopamine and noradrenaline turnover following growth hormone administration. Neuroscience Letters. 5: 83-9. PMID 19604975 DOI: 10.1016/0304-3940(77)90169-0  0.506
2001 Andersson K, Arner P. Systemic nicotine stimulates human adipose tissue lipolysis through local cholinergic and catecholaminergic receptors. International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association For the Study of Obesity. 25: 1225-32. PMID 11477508 DOI: 10.1038/Sj.Ijo.0801654  0.318
1998 Herrera-Marschitz M, Goiny M, You ZB, Meana JJ, Engidawork E, Chen Y, Rodriguez-Puertas R, Broberger C, Andersson K, Terenius L, Hökfelt T, Ungerstedt U. Release of endogenous excitatory amino acids in the neostriatum of the rat under physiological and pharmacologically-induced conditions. Amino Acids. 14: 197-203. PMID 9871461 DOI: 10.1007/Bf01345262  0.39
1997 Chen Y, Herrera-Marschitz M, Bjelke B, Blum M, Gross J, Andersson K. Perinatal asphyxia-induced changes in rat brain tyrosine hydroxylase-immunoreactive cell body number: effects of nicotine treatment. Neuroscience Letters. 221: 77-80. PMID 9121704 DOI: 10.1016/S0304-3940(96)13293-6  0.379
1996 Blum M, Wu G, Mudó G, Belluardo N, Andersson K, Agnati LF, Fuxe K. Chronic continuous infusion of (-)nicotine reduces basic fibroblast growth factor messenger RNA levels in the ventral midbrain of the intact but not of the 6-hydroxydopamine-lesioned rat. Neuroscience. 70: 169-77. PMID 8848122 DOI: 10.1016/0306-4522(95)00364-O  0.436
1996 Herrera-Marschitz M, You ZB, Goiny M, Meana JJ, Silveira R, Godukhin OV, Chen Y, Espinoza S, Pettersson E, Loidl CF, Lubec G, Andersson K, Nylander I, Terenius L, Ungerstedt U. On the origin of extracellular glutamate levels monitored in the basal ganglia of the rat by in vivo microdialysis. Journal of Neurochemistry. 66: 1726-35. PMID 8627331 DOI: 10.1046/J.1471-4159.1996.66041726.X  0.36
1995 Andersson K, Arner P. Cholinoceptor-mediated effects on glycerol output from human adipose tissue using in situ microdialysis British Journal of Pharmacology. 115: 1155-1162. PMID 7582538 DOI: 10.1111/J.1476-5381.1995.Tb15018.X  0.337
1992 Jansson A, Andersson K, Bjelke B, Eneroth P, Fuxe K. Effects of a postnatal exposure to cigarette smoke on hypothalamic catecholamine nerve terminal systems and on neuroendocrine function in the postnatal and adult male rat. Evidence for long-term modulation of anterior pituitary function. Acta Physiologica Scandinavica. 144: 453-62. PMID 1605047 DOI: 10.1111/j.1748-1716.1992.tb09320.x  0.478
1990 Fuxe K, Janson AM, Jansson A, Andersson K, Eneroth P, Agnati LF. Chronic nicotine treatment increases dopamine levels and reduces dopamine utilization in substantia nigra and in surviving forebrain dopamine nerve terminal systems after a partial di-mesencephalic hemitransection. Naunyn-Schmiedeberg's Archives of Pharmacology. 341: 171-81. PMID 2342600 DOI: 10.1007/Bf00169727  0.52
1990 Fuxe K, Agnati LF, Jansson A, von Euler G, Tanganelli S, Andersson K, Eneroth P. Regulation of endocrine function by the nicotinic cholinergic receptor. Ciba Foundation Symposium. 152: 113-27; discussion 1. PMID 2209250  0.462
1989 Jansson A, Andersson K, Fuxe K, Bjelke B, Eneroth P. Effects of combined pre- and postnatal treatment with nicotine on hypothalamic catecholamine nerve terminal systems and neuroendocrine function in the 4-week old and adult male and female diestrous rat. Journal of Neuroendocrinology. 1: 455-64. PMID 19210417 DOI: 10.1111/j.1365-2826.1989.tb00147.x  0.536
1989 Andersson K, Fuxe K, Eneroth P, Jansson A, Härfstrand A. Effects of withdrawal from chronic exposure to cigarette smoke on hypothalamic and preoptic catecholamine nerve terminal systems and on the secretion of pituitary hormones in the male rat. Naunyn-Schmiedeberg's Archives of Pharmacology. 339: 387-96. PMID 2739753 DOI: 10.1007/Bf00736052  0.493
1989 Fuxe K, Andersson K, Eneroth P, Jansson A, von Euler G, Tinner B, Bjelke B, Agnati LF. Neurochemical mechanisms underlying the neuroendocrine actions of nicotine: focus on the plasticity of central cholinergic nicotinic receptors. Progress in Brain Research. 79: 197-207. PMID 2685896 DOI: 10.1016/S0079-6123(08)62479-6  0.487
1989 Fuxe K, Andersson K, Eneroth P, Härfstrand A, Agnati LF. Neuroendocrine actions of nicotine and of exposure to cigarette smoke: medical implications. Psychoneuroendocrinology. 14: 19-41. PMID 2660182 DOI: 10.1016/0306-4530(89)90054-1  0.516
1989 Janson AM, Fuxe K, Agnati LF, Jansson A, Bjelke B, Sundström E, Andersson K, Härfstrand A, Goldstein M, Owman C. Protective effects of chronic nicotine treatment on lesioned nigrostriatal dopamine neurons in the male rat. Progress in Brain Research. 79: 257-65. PMID 2587746 DOI: 10.1016/S0079-6123(08)62485-1  0.471
1989 Tinner B, Fuxe K, Köhler C, Hersh L, Andersson K, Jansson A, Goldstein M, Agnati LF. Evidence for the existence of a population of arcuate neurons costoring choline acetyltransferase and tyrosine hydroxylase immunoreactivities in the male rat. Neuroscience Letters. 99: 44-9. PMID 2568607 DOI: 10.1016/0304-3940(89)90262-0  0.501
1988 Fuxe K, Agnati LF, Andersson K, Cintra A, Härfstrand A, Zoli M, Eneroth P, Goldstein M. D1 receptor mechanisms in the median eminence and their inhibitory regulation of LHRH release. Neurochemistry International. 13: 165-78. PMID 20501286 DOI: 10.1016/0197-0186(88)90053-8  0.499
1988 Andersson K, Fuxe K, Eneroth P, Härfstrand A, Agnati LF. Involvement of D1 dopamine receptors in the nicotine-induced noradrenaline release from hypothalamic and preoptic noradrenaline nerve terminal systems. Neurochemistry International. 13: 159-63. PMID 20501285 DOI: 10.1016/0197-0186(88)90052-6  0.543
1988 Härfstrand A, Adem A, Fuxe K, Agnati L, Andersson K, Nordberg A. Distribution of nicotinic cholinergic receptors in the rat tel- and diencephalon: a quantitative receptor autoradiographical study using [3H]-acetylcholine, [alpha-125I]bungarotoxin and [3H]nicotine. Acta Physiologica Scandinavica. 132: 1-14. PMID 3223299 DOI: 10.1111/J.1748-1716.1988.Tb08291.X  0.452
1988 Andersson K, Fuxe K, Eneroth P, Härfstrand A, Agnati LF. Involvement of D1 dopamine receptors in the nicotine-induced neuro-endocrine effects and depletion of diencephalic catecholamine stores in the male rat. Neuroendocrinology. 48: 188-200. PMID 2975769 DOI: 10.1159/000125007  0.539
1988 Andersson K, Eneroth P, Fuxe K, Härfstrand A. Effects of acute intermittent exposure to cigarette smoke on hypothalamic and preoptic catecholamine nerve terminal systems and on neuroendocrine function in the diestrous rat. Naunyn-Schmiedeberg's Archives of Pharmacology. 337: 131-9. PMID 2966898 DOI: 10.1007/Bf00169239  0.503
1988 Janson AM, Fuxe K, Agnati LF, Kitayama I, Härfstrand A, Andersson K, Goldstein M. Chronic nicotine treatment counteracts the disappearance of tyrosine-hydroxylase-immunoreactive nerve cell bodies, dendrites and terminals in the mesostriatal dopamine system of the male rat after partial hemitransection. Brain Research. 455: 332-45. PMID 2900058 DOI: 10.1016/0006-8993(88)90092-3  0.527
1988 Fuxe K, Agnati LF, Cintra A, Andersson K, Eneroth P, Härfstrand A, Zoli M, Goldstein M. Studies on central D1 receptors role in volume transmission, neuroendrocrine regulation and release of noradrenaline. Advances in Experimental Medicine and Biology. 235: 83-119. PMID 2852453 DOI: 10.1007/978-1-4899-2723-1_7  0.394
1987 Härfstrand A, Fuxe K, Andersson K, Agnati L, Janson AM, Nordberg A. Partial di-mesencephalic hemitransections produce disappearance of [3H]nicotine binding in discrete regions of rat brain. Acta Physiologica Scandinavica. 130: 161-3. PMID 3591387 DOI: 10.1111/J.1748-1716.1987.Tb08122.X  0.456
1987 Fuxe K, Martire M, von Euler G, Agnati LF, Hansson T, Andersson K, Gustafsson JA, Härfstrand A. Effects of subacute treatment with toluene on cerebrocortical alpha- and beta-adrenergic receptors in the rat. Evidence for an increased number and a reduced affinity of beta-adrenergic receptors. Acta Physiologica Scandinavica. 130: 307-11. PMID 3037856 DOI: 10.1111/j.1748-1716.1987.tb08141.x  0.431
1987 Andersson K, Fuxe K, Eneroth P, Agnati LF, Härfstrand A. Effects of acute continuous exposure of the rat to cigarette smoke on amine levels and utilization in discrete hypothalamic catecholamine nerve terminal systems and on neuroendocrine function. Naunyn-Schmiedeberg's Archives of Pharmacology. 335: 521-8. PMID 2886921 DOI: 10.1007/Bf00169118  0.517
1986 Fuxe K, Andersson K, Härfstrand A, Agnati LF, Eneroth P, Janson AM, Vale W, Thorner M, Goldstein M. Medianosomes as integrative units in the external layer of the median eminence. Studies on grf/catecholamine and somatostatin/catecholamine interactions in the hypothalamus of the male rat. Neurochemistry International. 9: 155-70. PMID 20493113 DOI: 10.1016/0197-0186(86)90044-6  0.483
1986 Härfstrand A, Fuxe K, Agnati LF, Eneroth P, Zini I, Zoli M, Andersson K, von Euler G, Terenius L, Mutt V, Goldstein M. Studies on neuropeptide Y-catecholamine interactions in the hypothalamus and in the forebrain of the male rat. Relationship to neuroendocrine function. Neurochemistry International. 8: 355-76. PMID 20493065 DOI: 10.1016/0197-0186(86)90009-4  0.533
1986 Andersson K, Eneroth P, Fuxe K, Härfstrand A. Nicotine-induced increases in brain luteinizing hormone releasing hormone-like immunoreactivity and in serum luteinizing hormone levels of the male rat. Neuroscience Letters. 71: 289-92. PMID 3540734 DOI: 10.1016/0304-3940(86)90635-X  0.506
1986 Fuxe K, Agnati LF, Härfstrand A, Janson AM, Neumeyer A, Andersson K, Ruggeri M, Zoli M, Goldstein M. Morphofunctional studies on the neuropeptide Y/adrenaline costoring terminal systems in the dorsal cardiovascular region of the medulla oblongata. Focus on receptor-receptor interactions in cotransmission. Progress in Brain Research. 68: 303-20. PMID 3031731 DOI: 10.1016/S0079-6123(08)60246-0  0.469
1986 Fuxe K, Agnati LF, Härfstrand A, Andersson K, Mascagni F, Zoli M, Kalia M, Battistini N, Benfenati F, Hökfelt T. Studies on peptide comodulator transmission. New perspective on the treatment of disorders of the central nervous system. Progress in Brain Research. 66: 341-68. PMID 3024227 DOI: 10.1016/S0079-6123(08)64610-5  0.444
1986 Fuxe K, Andersson K, Härfstrand A, Agnati LF. Increases in dopamine utilization in certain limbic dopamine terminal populations after a short period of intermittent exposure of male rats to cigarette smoke. Journal of Neural Transmission. 67: 15-29. PMID 2878061 DOI: 10.1007/Bf01243356  0.515
1985 Andersson K, Eneroth P, Fuxe K, Mascagni F, Agnati LF. Effects of chronic exposure to cigarette smoke on amine levels and turnover in various hypothalamic catecholamine nerve terminal systems and on the secretion of pituitary hormones in the male rat. Neuroendocrinology. 41: 462-6. PMID 3001559 DOI: 10.1159/000124220  0.488
1985 Fuxe K, Agnati LF, Vanderhaeghen J, Tatemoto K, Andersson K, Eneroth P, Härfstrand A, Euler GV, Toni R, Goldstein M, Mutt V. Cholecystokinin Neuron Systems and Their Interactions with the Presynaptic Features of the Dopamine Neuron Systems Annals of the New York Academy of Sciences. 448: 231-254. PMID 2862825 DOI: 10.1111/J.1749-6632.1985.Tb29921.X  0.477
1985 Andersson K, Fuxe K, Eneroth P, Mascagni F, Agnati LF. Effects of acute intermittent exposure to cigarette smoke on catecholamine levels and turnover in various types of hypothalamic DA and NA nerve terminal systems as well as on the secretion of adenohypophyseal hormones and corticosterone. Acta Physiologica Scandinavica. 124: 277-85. PMID 2861716 DOI: 10.1111/j.1748-1716.1985.tb07662.x  0.502
1985 Andersson K, Fuxe K, Agnati LF. Determinations of catecholamine half-lives and turnover rates in discrete catecholamine nerve terminal systems of the hypothalamus, the preoptic region and the forebrain by quantitative histofluorimetry. Acta Physiologica Scandinavica. 123: 411-26. PMID 2859735 DOI: 10.1111/j.1748-1716.1985.tb07608.x  0.435
1985 Fuxe K, Siegel RA, Andersson K, Eneroth P, Mascagni F, Agnati LF. Acute continuous exposure to cigarette smoke produces discrete changes in cholecystokinin and substance P levels in the hypothalamus and preoptic area of the male rat. Acta Physiologica Scandinavica. 125: 437-43. PMID 2417451 DOI: 10.1111/j.1748-1716.1985.tb07740.x  0.49
1985 Lin MT, Shian LR, Demarest KT, Moore KE, Riegle GD, Gaillard RC, Favrod-Coune CA, Capponi AM, Muller AF, Cavagnini F, Invitti C, Danesi L, Passamonti M, Fossati R, Emanuele NV, ... ... Andersson K, et al. Subject Index Vol. 41, 1985 Neuroendocrinology. 41: 535-537. DOI: 10.1159/000124235  0.336
1985 Lin MT, Shian LR, Demarest KT, Moore KE, Riegle GD, Gaillard RC, Favrod-Coune CA, Capponi AM, Muller AF, Cavagnini F, Invitti C, Danesi L, Passamonti M, Fossati R, Emanuele NV, ... ... Andersson K, et al. Contents, Vol. 41, 1985 Neuroendocrinology. 41. DOI: 10.1159/000124217  0.343
1984 Fuxe K, Agnati LF, Andersson K, Eneroth P, Härfstrand A, Goldstein M, Zoli M. Studies on neurotensin catecholamine interactions in the hypothalamus and in the forebrain of the male rat Neurochemistry International. 6: 737-750. PMID 20488102 DOI: 10.1016/0197-0186(84)90005-6  0.529
1984 Fuxe K, Andersson K, Hansson T, Agnati LF, Eneroth P, Gustafsson JA. Central catecholamine neurons and exposure to dichloromethane. Selective changes in amine levels and turnover in tel- and diencephalic DA and NA nerve terminal systems and in the secretion of anterior pituitary hormones in the male rat. Toxicology. 29: 293-305. PMID 6701900 DOI: 10.1016/0300-483X(84)90161-6  0.539
1984 Andersson K, Fuxe K, Agnati LF, Eneroth P, Camurri M. Luteinizing hormone-releasing hormone increases dopamine turnover in the lateral palisade zone of the median eminence and reduces noradrenaline turnover in the nuc. preopticus medialis of the hypophysectomized male rat. Neuroscience Letters. 45: 253-258. PMID 6145128 DOI: 10.1016/0304-3940(84)90235-0  0.536
1984 Andersson K, Agnati LF, Fuxe K, Eneroth P, Härfstrand A, Benfenati F. Corticotropin-releasing factor increases noradrenaline turnover in the median eminence and reduces noradrenaline turnover in the paraventricular region of the hypophysectomized male rat. Acta Physiologica Scandinavica. 120: 621-4. PMID 6091416 DOI: 10.1111/j.1748-1716.1984.tb07430.x  0.484
1983 Fuxe K, Yukimura T, Ganten D, Härfstrand A, Andersson K, Eneroth P, Zini I, Agnati LF, Unger T. Effects of chronic sino-aortic denervation in male rats on regional catecholamine levels and turnover and on neuroendocrine function. European Journal of Pharmacology. 87: 145-9. PMID 6840185 DOI: 10.1016/0014-2999(83)90062-6  0.458
1983 Andersson K, Fuxe K, Eneroth P, Agnati LF. Involvement of cholinergic nicotine-like receptors as modulators of amine turnover in various types of hypothalamic dopamine and noradrenaline nerve terminal systems and of prolactin, LH, FSH and TSH secretion in the castrated male rat. Acta Physiologica Scandinavica. 116: 41-50. PMID 6818838 DOI: 10.1111/J.1748-1716.1982.TB10597.X  0.54
1983 Andersson K, Fuxe K, Agnati LF, Ganten D, Zini I, Eneroth P, Mascagni F, Infantillina F. Intraventricular injections of renin increase amine turnover in the tuberoinfundibular dopamine neurons and reduce the secretion of prolactin in the male rat. Acta Physiologica Scandinavica. 116: 317-20. PMID 6762803 DOI: 10.1111/J.1748-1716.1982.TB07148.X  0.513
1983 Celani MF, Fuxe K, Agnati LF, Andersson K, Hansson T, Gustafsson JA, Battistini N, Eneroth P. Effects of subacute treatment with toluene on central monoamine receptors in the rat. Reduced affinity in [3H]5-hydroxytryptamine binding sites and in [3H]spiperone binding sites linked to dopamine receptors. Toxicology Letters. 17: 275-81. PMID 6623522 DOI: 10.1016/0378-4274(83)90238-2  0.47
1983 Siegel RA, Andersson K, Fuxe K, Eneroth P, Lindbom LO, Agnati LF. Rapid and discrete changes in hypothalamic catecholamine nerve terminal systems induced by audiogenic stress, and their modulation by nicotine - Relationship to neuroendocrine function European Journal of Pharmacology. 91: 49-56. PMID 6617738 DOI: 10.1016/0014-2999(83)90360-6  0.494
1983 Andersson K, Siegel R, Fuxe K, Eneroth P. Intravenous injections of nicotine induce very rapid and discrete reductions of hypothalamic catecholamine levels associated with increases of ACTH, vasopressin and prolactin secretion. Acta Physiologica Scandinavica. 118: 35-40. PMID 6312746 DOI: 10.1111/J.1748-1716.1983.TB07237.X  0.507
1983 Fuxe K, Andersson K, Eneroth P, Siegel RA, Agnati LF. Immobilization stress-induced changes in discrete hypothalamic catecholamine levels and turnover, their modulation by nicotine and relationship to neuroendocrine function Acta Physiologica Scandinavica. 117: 421-426. PMID 6308959 DOI: 10.1111/J.1748-1716.1983.TB00016.X  0.499
1983 Fuxe K, Agnati LF, Benfenati F, Andersson K, Camurri M, Zoli M. Evidence for the existence of a dopamine receptor of the D-1 type in the rat median eminence. Neuroscience Letters. 43: 185-90. PMID 6231493 DOI: 10.1016/0304-3940(83)90185-4  0.482
1983 Fuxe K, Ogren SO, Agnati LF, Benfenati F, Fredholm B, Andersson K, Zini I, Eneroth P. Chronic antidepressant treatment and central 5-HT synapses. Neuropharmacology. 22: 389-400. PMID 6190101 DOI: 10.1016/0028-3908(83)90188-0  0.392
1982 Andersson K, Fuxe K, Eneroth P, Nyberg F, Roos P. Rat prolactin and hypothalamic catecholamine nerve terminal systems. Evidence for rapid and discrete increases in dopamine and noradrenaline turnover in the hypophysectomized male rat. European Journal of Pharmacology. 76: 261-5. PMID 7333359 DOI: 10.1016/0014-2999(81)90510-0  0.542
1982 Andersson K, Fuxe K, Eneroth P, Agnati LF, Gustafsson JÅ. Interactions of nicotine and pentobarbitone in the regulation of telencephalic and hypothalamic catecholamine levels and turnover and of adenohypophyseal hormone secretion in the normal male rat. Naunyn-Schmiedebergs Archives of Pharmacology. 321: 287-292. PMID 7167203 DOI: 10.1007/Bf00498515  0.506
1982 Fuxe K, Andersson K, Nilsen OG, Toftgård R, Eneroth P, Gustafsson JA. Toluene and telencephalic dopamine: selective reduction of amine turnover in discrete DA nerve terminal systems of the anterior caudate nucleus by low concentrations of toluene. Toxicology Letters. 12: 115-23. PMID 7112606 DOI: 10.1016/0378-4274(82)90173-4  0.505
1982 Fuxe K, Vincent M, Andersson K, Härfstrand A, Agnati LF, Sassard J, Benfenati F, Hökfelt T. Selective reduction of adrenaline turnover in the dorsal midline area of the caudal medulla oblongata and increase of hypothalamic adrenaline levels in the Lyon strain of genetically hypertensive rats. European Journal of Pharmacology. 77: 187-91. PMID 7060635 DOI: 10.1016/0014-2999(82)90018-8  0.466
1981 Fuxe K, Andersson K, Locatelli V, Agnati LF, Hökfelt T, Skirboll L, Mutt V. Cholecystokinin peptides produce marked reduction of dopamine turnover in discrete areas in the rat brain following intraventricular injection. European Journal of Pharmacology. 67: 329-31. PMID 7461038 DOI: 10.1016/0014-2999(80)90521-X  0.479
1981 Andersson K, Fuxe K, Agnati LF. Effects of single injections of nicotine on the ascending dopamine pathways in the rat. Evidence for increases of dopamine turnover in the mesostriatal and mesolimbic dopamine neurons. Acta Physiologica Scandinavica. 112: 345-7. PMID 7293802 DOI: 10.1111/J.1748-1716.1981.TB06827.X  0.511
1981 Andersson K, Fuxe K, Nilsen OG, Toftgård R, Eneroth P, Gustafsson JA. Production of discrete changes in dopamine and noradrenaline levels and turnover in various parts of the rat brain following exposure to xylene, ortho-, meta-, and para-xylene, and ethylbenzene. Toxicology and Applied Pharmacology. 60: 535-48. PMID 7292492 DOI: 10.1016/0041-008X(81)90340-9  0.523
1981 Fuxe K, Agnati LF, Köhler C, Kuonen D, Ogren SO, Andersson K, Hökfelt T. Characterization of normal and supersensitive dopamine receptors: effects of ergot drugs and neuropeptides. Journal of Neural Transmission. 51: 3-37. PMID 7264628 DOI: 10.1007/BF01664003  0.483
1981 Fuxe K, Ögren S-, Agnati LF, Eneroth P, Holm AC, Andersson K. Long-term treatment with zimelidine leads to a reduction in 5-hydroxytryptamine neurotransmission within the central nervous system of the mouse and rat Neuroscience Letters. 21: 57-62. PMID 6259561 DOI: 10.1016/0304-3940(81)90057-4  0.439
1980 Andersson K, Fuxe K, Toftgård R, Nilsen OG, Eneroth P, Gustafsson JA. Toluene-induced activation of certain hypothalamic and median eminence catecholamine nerve terminal systems of the male rat and its effects on anterior pituitary hormone secretion. Toxicology Letters. 5: 393-8. PMID 7394835 DOI: 10.1016/0378-4274(80)90021-1  0.515
1980 Andersson K, Schwarcz R, Fuxe K. Compensatory bilateral changes in dopamine turnover after striatal kainate lesion. Nature. 283: 94-6. PMID 7188627 DOI: 10.1038/283094A0  0.467
1980 Agnati LF, Fuxe K, Andersson K, Benfenati F, Cortelli P, D'Alessandro R. The mesolimbic dopamine system: evidence for a high amine turnover and for a heterogeneity of the dopamine neuron population. Neuroscience Letters. 18: 45-51. PMID 7052480 DOI: 10.1016/0304-3940(80)90211-6  0.466
1980 Fuxe K, Ganten D, Jonsson G, Bolme P, Agnati LF, Andersson K, Goldstein M, Hökfelt T. Evidence for a selective reduction of adrenaline turnover in the dorsal midline area of the caudal medulla oblongata of young spontaneous hypertensive rats. Acta Physiologica Scandinavica. 107: 397-9. PMID 543430 DOI: 10.1111/J.1748-1716.1979.TB06492.X  0.325
1980 Fuxe K, Ganten G, Jonsson G, Agnati LF, Andersson K, Hökfelt T, Bolme P, Goldstein M, Hallman H, Unger T, Rascher W. Catecholamine turnover changes in hypothalamus and dorsal midline area of the caudal medulla oblongata of spontaneously hypertensive rats. Neuroscience Letters. 15: 283-8. PMID 530533 DOI: 10.1016/0304-3940(79)96127-5  0.392
1980 Fuxe K, Jonsson G, Bolme P, Andersson K, Agnati LF, Goldstein M, Hökfelt T. Reduction of adrenaline turnover in cardiovascular areas of rat medulla oblongata by clonidine. Acta Physiologica Scandinavica. 107: 177-9. PMID 525381 DOI: 10.1111/J.1748-1716.1979.TB06459.X  0.32
1979 Kiianmaa K, Andersson K, Fuxe K. On the role of ascending dopamine systems in the control of voluntary ethanol intake and ethanol intoxication. Pharmacology, Biochemistry, and Behavior. 10: 603-8. PMID 572555 DOI: 10.1016/0091-3057(79)90240-5  0.446
Show low-probability matches.